{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:40:29Z","timestamp":1760604029386,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.plefa.2021.102325","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T05:38:45Z","timestamp":1628401125000},"page":"102325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["New \u03b2-ketophosphonates for the synthesis of prostaglandin analogues. 1. Phosphonates with a bicyclo[3.3.0]octene scaffold spaced by a methylene group from the \u03b2-ketone"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3867-1064","authenticated-orcid":false,"given":"Comstantin","family":"T\u0103nase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miron Teodor","family":"C\u0103proiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Dr\u0103ghici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.plefa.2021.102325_bib0001","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/cr00020a007","article-title":"Synthesis of therapeutically useful prostaglandin and prostacyclin analogs","volume":"93","author":"Collins","year":"1993","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.plefa.2021.102325_bib0002","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/cr068365a","article-title":"Recent Developments in the Synthesis of Prostaglandins and Analogues","volume":"107","author":"Das","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.plefa.2021.102325_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041572","article-title":"Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs","volume":"22","author":"T\u0103nase","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2021.102325_bib0004","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1039\/D0NJ04594B","article-title":"New \u00df-ketophosphonates for the synthesis of prostaglandin analogues. 2. Phosphonates with a bicyclo[3.3.0]octene and bicyclo[3.3.0]octane scaffolds linked to the \u00df-ketone group","volume":"44","author":"T\u0103nase","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.plefa.2021.102325_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136787","article-title":"\u03b2-Ketophosphonates with Pentalenofuran Scaffolds Linked to the Ketone Group for the Synthesis of Prostaglandin Analogs","volume":"22","author":"T\u0103nase","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2021.102325_bib0006","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1039\/C9NJ01186B","article-title":"Secondary Compounds in the Catalytic Hydrogenation of Enone and Allylic Alcohol Prostaglandin Intermediates: Isolation, Characterization, X-Ray Crystallography","volume":"43","author":"T\u0103nase","year":"2019","journal-title":"New J. Chem."},{"issue":"45","key":"10.1016\/j.plefa.2021.102325_bib0007","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1021\/ja002974x","article-title":"Highly Stereocontrolled Synthesis of Carbacyclin from Acyclic Starting Materials via Ti(II)-Mediated Tandem Cyclization","volume":"122","author":"Okamoto","year":"2000","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.plefa.2021.102325_bib0008","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1021\/jo060551t","article-title":"Fully Stereocontrolled Syntheses of 3-Oxacarbacyclin and Carbacyclin by the Conjugate Addition-Azoalkene-Asymmetric Olefination Strategy","volume":"71","author":"Kim","year":"2006","journal-title":"J. Org. Chem."},{"issue":"23","key":"10.1016\/j.plefa.2021.102325_bib0009","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1021\/jo048738c","article-title":"Diastereoselective Total Synthesis of Isocarbacyclin from l-Ascorbic Acid","volume":"69","author":"Ishikawa","year":"2004","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.plefa.2021.102325_bib0010","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/S0040-4020(01)92573-6","article-title":"The structure and chemistry of hirsutic acid","volume":"23","author":"Comer","year":"1967","journal-title":"Tetrahedron"},{"issue":"12","key":"10.1016\/j.plefa.2021.102325_bib0011","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1248\/cpb.38.3230","article-title":"A Total Synthesis of (+)-Hirsutic Acid","volume":"38","author":"Nishida","year":"1990","journal-title":"Chem. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.plefa.2021.102325_bib0012","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/v2012-037","article-title":"A short formal total synthesis of (\u00b1)-hirsutic acid","volume":"90","author":"Revol","year":"2012","journal-title":"Can, J. Chem."},{"key":"10.1016\/j.plefa.2021.102325_bib0013","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1351\/pac199668030675","article-title":"Photocyclization-fragmentation route to di- and triquinanes: Stereocontrolled asymmetric synthesis of (-)-isocomene","volume":"68","author":"Rawal","year":"1996","journal-title":"Pure & Appl. Chem."},{"key":"10.1016\/j.plefa.2021.102325_bib0014","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1021\/jo01336a071","article-title":"Stereospecific total synthesis of (.+-.)-isocomene (berkheyaradulene)","volume":"44","author":"Paquette","year":"1979","journal-title":"J. Org. Chem."},{"issue":"14","key":"10.1016\/j.plefa.2021.102325_bib0015","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/ja00274a050","article-title":"Total synthesis of (-)-coriolin","volume":"108","author":"Demuth","year":"1986","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.plefa.2021.102325_bib0016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7164\/antibiotics.27.301","article-title":"Absolute configuration of coriolin, a sesquiterpene antibiotic from Coriolus consors","volume":"27","author":"Nakayama","year":"1974","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"32","key":"10.1016\/j.plefa.2021.102325_bib0017","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/S0040-4039(01)88256-3","article-title":"The structure of pentalenolactone (PA-132)Setsuo Takeuchi","volume":"10","author":"Takeuki","year":"1969","journal-title":"Tetrahedrom Lett"},{"issue":"19","key":"10.1016\/j.plefa.2021.102325_bib0018","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1021\/ja00019a051","article-title":"Highly stereo- and regiocontrolled cyclopentannulation via allylphosphonate conjugate addition and hydroboration-oxidation-elimination. Synthesis of pentalenic acid with virtually complete stereo- and regiocontrol","volume":"113","author":"Agnel","year":"1991","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.plefa.2021.102325_bib0019","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1021\/acs.joc.9b01349","article-title":"Formal Synthesis of (\u00b1)-Pentalenolactone A Methyl Ester","volume":"84","author":"Niu","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.plefa.2021.102325_bib0020","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1021\/ja00532a049","article-title":"Total synthesis of dl-quadrone","volume":"102","author":"Danishefsky","year":"1980","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.plefa.2021.102325_bib0021","doi-asserted-by":"crossref","first-page":"17326","DOI":"10.1021\/acsomega.8b02994","article-title":"Benefits of Unconventional Methods in the Total Synthesis of Natural Products","volume":"3","author":"Hudlicky","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.plefa.2021.102325_bib0022","unstructured":"C. T\u0103nase, M.T. C\u0103proiu, C. Dr\u0103ghici, \u03b2-Ketophosphonates with a functionalized pentalenofurane fragment for obtaining new prostaglandin analogs, Patent Pending RO a00516\/14.08.2020."},{"key":"10.1016\/j.plefa.2021.102325_bib0023","unstructured":"C. T\u0103nase, M.T. C\u0103proiu, C. Dr\u0103ghici, A. Hanganu, L. Pintilie, M. Maganu, The First Pentalenofurane Scaffold in the \u03c9-side chain of a PGF1 analog. To be submitted."},{"issue":"23","key":"10.1016\/j.plefa.2021.102325_bib0024","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1021\/ja00975a057","article-title":"The Synthesis of Olefins from O,O'-Dialkyl \u03b2-Lithioalkylphosphonothioate Esters","volume":"88","author":"Corey","year":"1966","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.plefa.2021.102325_bib0025","first-page":"119","article-title":"Prostaglandins XXX. Syntesis of E and F 11-desoxyprostaglandin analogs","volume":"26","author":"Tolstikov","year":"1990","journal-title":"Zhur. Org. Khim."},{"issue":"3","key":"10.1016\/j.plefa.2021.102325_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1351\/pac199971030473","article-title":"New phosphonate-mediated syntheses of cyclopentanoids and prostaglandins","volume":"71","author":"Mikolajczyk","year":"1999","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.plefa.2021.102325_bib0027","unstructured":"I. Kalder, V. Simonidesz, P. Gyory, F. Szabo, J. Oery, Novel Prostaglandin Intermediates Modified in the Omega -Chain and Process for Preparing Same, WO88\/07537, 6 Oct.1988."},{"key":"10.1016\/j.plefa.2021.102325_bib0028","unstructured":"J.S. Bindra, M.R. Johnson, Substituted \u03c9-pentanorprostaglandins, US4024179, 17.05.1977."},{"key":"10.1016\/j.plefa.2021.102325_bib0029","unstructured":"M. Harre, J. Westermann, K. Nickish, H. Rewinkel, DE 4028864, Process for Making E\/Z Mixtures of 2-(6-Alkyl-Bicyclo-[3.3.0]-Octane-3-Ylidene)-Acetic Acid Derivatives with a Preponderant Proportion of the E-Isomers, 12 March 1992."},{"key":"10.1016\/j.plefa.2021.102325_bib0030","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/S0040-4039(01)85513-1","article-title":"Une voie simple et efficace d'acces aux \u03b2-cetophosphonates","volume":"33","author":"Savignac","year":"1976","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.plefa.2021.102325_bib0031","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1055\/s-1976-24197","article-title":"A Direct Synthesis of Diethyl 1-Alkyl-2-Oxoalkanephosphonates","volume":"11","author":"Mathey","year":"1976","journal-title":"Synthesis"},{"issue":"29","key":"10.1016\/j.plefa.2021.102325_bib0032","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1016\/S0040-4039(00)97561-0","article-title":"\u03b2-cetophosphonates: Precurseurs d'analogues du LTB4","volume":"31","author":"Durand","year":"1990","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.plefa.2021.102325_bib0033","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1021\/jo00097a058","article-title":"New Syntheses of Some Functionalized and Acetylenic beta-Keto Phosphonates","volume":"59","author":"Delmarche","year":"1994","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.plefa.2021.102325_bib0034","first-page":"28","volume":"21","author":"Lui","year":"1990","journal-title":"Chinese J of Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.plefa.2021.102325_bib0035","first-page":"195","article-title":"1,2,3,3a,4,6a-Hexahydro-1,3-Pentalenedimethanol, Mono and Bis OH-Protected Derivatives, Useful Intermediates for Fine Organic Synthesis","volume":"53","author":"T\u0103nase","year":"2008","journal-title":"Rev. Roum. Chim."},{"key":"10.1016\/j.plefa.2021.102325_bib0036","unstructured":"C. T\u0103nase, M.T. C\u0103proiu, C. Dr\u0103ghici, \u03b2-Ketophosphonates with a hexahydro- and octahydropentalene functionalized fragment for obtaining new prostaglandin analogs, Patent Pending RO a00517\/14.08.2020."},{"key":"10.1016\/j.plefa.2021.102325_bib0037","first-page":"43","article-title":"New \u03b2-ketophosphonates for the Synthesis of Prostaglandin Analogues. 1. Phosphonates with a Bicyclo[3.3.0]octene Scaffold Spaced by a Methylene Group from the \u03b2-ketone","volume":"57","author":"T\u0103nase","year":"2020","journal-title":"Proceedings"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327821000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327821000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:11:38Z","timestamp":1760602298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327821000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":37,"alternative-id":["S0952327821000879"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2021.102325","relation":{},"ISSN":["0952-3278"],"issn-type":[{"type":"print","value":"0952-3278"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New \u03b2-ketophosphonates for the synthesis of prostaglandin analogues. 1. Phosphonates with a bicyclo[3.3.0]octene scaffold spaced by a methylene group from the \u03b2-ketone","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2021.102325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102325"}}